Rapid Exoproteome
Antigen Profiling (REAP)

is a discovery engine for functional autoantibody reactivities across the human exoproteome.
Exoproteome for biologically active reactivities
-
Autoantibodies that target extracellular and secreted proteins (collectively, the “exoproteome”) exert potent biological effects that shape health and disease. Prior to REAP, these reactivities were difficult to detect accurately at scale.

By focusing on the exoproteome, REAP captures autoantibody reactivities most likely to exert direct biological effects.
Correctly folded proteins for sensitivity
+
Genetic barcoding for scale
+

Seravista

Population-scale profiling meets modern machine learning
Computation to resolve
protective associations
-
Seravista identifies associations between autoantibody reactivities and longitudinal clinical outcomes, prioritizing hypotheses for orthogonal validation.

Seravista’s machine learning models are refined with data from every new patient, continuously improving our understanding of the role of different autoantibodies in disease.
High-quality data for actionable insights
+